These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37197802)

  • 1. Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.
    Armstrong JF; Campo B; Alexander SPH; Arendse LB; Cheng X; Davenport AP; Faccenda E; Fidock DA; Godinez-Macias KP; Harding SD; Kato N; Lee MCS; Luth MR; Mazitschek R; Mittal N; Niles JC; Okombo J; Ottilie S; Pasaje CFA; Probst AS; Rawat M; Rocamora F; Sakata-Kato T; Southan C; Spedding M; Tye MA; Yang T; Zhao N; Davies JA
    Br J Pharmacol; 2023 Aug; 180(15):1899-1929. PubMed ID: 37197802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY.
    Armstrong JF; Faccenda E; Harding SD; Pawson AJ; Southan C; Sharman JL; Campo B; Cavanagh DR; Alexander SPH; Davenport AP; Spedding M; Davies JA;
    Nucleic Acids Res; 2020 Jan; 48(D1):D1006-D1021. PubMed ID: 31691834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Screens in Antimalarial Drug Discovery.
    Hovlid ML; Winzeler EA
    Trends Parasitol; 2016 Sep; 32(9):697-707. PubMed ID: 27247245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out.
    Dechering KJ; Timmerman M; Rensen K; Koolen KMJ; Honarnejad S; Vos MW; Huijs T; Henderson RWM; Chenu E; Laleu B; Montefiore BC; Segall MD; Mills JEJ; Guantai EM; Duffy J; Duffey M
    SLAS Discov; 2022 Sep; 27(6):337-348. PubMed ID: 35872229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimalarial screening landscape-looking beyond the asexual blood stage.
    Yahiya S; Rueda-Zubiaurre A; Delves MJ; Fuchter MJ; Baum J
    Curr Opin Chem Biol; 2019 Jun; 50():1-9. PubMed ID: 30875617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimalarial pipeline.
    Hooft van Huijsduijnen R; Wells TN
    Curr Opin Pharmacol; 2018 Oct; 42():1-6. PubMed ID: 29860174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.
    Harding SD; Armstrong JF; Faccenda E; Southan C; Alexander SPH; Davenport AP; Pawson AJ; Spedding M; Davies JA;
    Nucleic Acids Res; 2022 Jan; 50(D1):D1282-D1294. PubMed ID: 34718737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections.
    Cowell AN; Winzeler EA
    Genome Med; 2019 Oct; 11(1):63. PubMed ID: 31640748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
    Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
    PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box.
    Reader J; van der Watt ME; Taylor D; Le Manach C; Mittal N; Ottilie S; Theron A; Moyo P; Erlank E; Nardini L; Venter N; Lauterbach S; Bezuidenhout B; Horatscheck A; van Heerden A; Spillman NJ; Cowell AN; Connacher J; Opperman D; Orchard LM; Llinás M; Istvan ES; Goldberg DE; Boyle GA; Calvo D; Mancama D; Coetzer TL; Winzeler EA; Duffy J; Koekemoer LL; Basarab G; Chibale K; Birkholtz LM
    Nat Commun; 2021 Jan; 12(1):269. PubMed ID: 33431834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemozoin and antimalarial drug discovery.
    Fong KY; Wright DW
    Future Med Chem; 2013 Aug; 5(12):1437-50. PubMed ID: 23919553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New horizons in antimalarial drug discovery in the last decade by chemoinformatic approaches.
    Ambre PK; Wavhale RD; Coutinho EC
    Comb Chem High Throughput Screen; 2015; 18(2):129-50. PubMed ID: 25543682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.